awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52597561-1E6064ED-CA26-4847-929D-041F2F5BB5D1
Q52597561-1E6064ED-CA26-4847-929D-041F2F5BB5D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52597561-1E6064ED-CA26-4847-929D-041F2F5BB5D1
A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer.
P2860
Q52597561-1E6064ED-CA26-4847-929D-041F2F5BB5D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52597561-1E6064ED-CA26-4847-929D-041F2F5BB5D1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7aa129d38a661bb583b97774194337d966f46297
P2860
Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial.